These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7529936)

  • 1. Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy.
    Kim JA; Kuban DA; el-Mahdi AM; Schellhammer PF
    Radiology; 1995 Feb; 194(2):545-9. PubMed ID: 7529936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
    Bissonette EA; Fulmer BR; Petroni GR; Moul JW; Theodorescu D
    J Urol; 2001 Oct; 166(4):1328-31; discussion 1331-2. PubMed ID: 11547067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
    Fowler JE; Bigler SA; Farabaugh PB
    Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
    Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
    J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
    Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
    Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer.
    Kuban DA; el-Mahdi AM; Schellhammer PF
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):307-16. PubMed ID: 7538499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of race on freedom from prostate-specific antigen failure in prostate cancer patients treated with definitive radiation therapy.
    Young CD; Lewis P; Weinberg V; Lee TT; Coleman CW; Roach M
    Semin Urol Oncol; 2000 May; 18(2):121-6. PubMed ID: 10875452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
    Eastham JA; Carver B; Katz J; Kattan MW
    Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.
    Klaassen Z; Howard L; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
    Cancer Epidemiol; 2015 Dec; 39(6):1066-70. PubMed ID: 26452418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 1989 patterns of care study for prostate cancer: five-year outcomes.
    Chuba PJ; Moughan J; Forman JD; Owen J; Hanks G
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):325-34. PubMed ID: 11380218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemical disease-free survival in localized carcinoma of prostate treated with external beam irradiation: comparison of American Society of Therapeutic Radiology and Oncology Consensus or 1 ng/mL as endpoint.
    Perez CA; Michalski JM; Lockett MA
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1287-96. PubMed ID: 11286836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
    Fowler JE; Bigler SA; Kilambi NK; Land SA
    Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of race on the efficacy of curative radiation therapy for carcinoma of the prostate.
    Hart KB; Porter AT; Shamsa F; Chuba PJ; Pontes JE; Forman JD
    Semin Urol Oncol; 1998 Nov; 16(4):227-31. PubMed ID: 9858330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.
    Fowler JE; Bigler SA; Bowman G; Kilambi NK
    J Urol; 2000 Jan; 163(1):137-42. PubMed ID: 10604331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen.
    Zhang W; Sesterhenn IA; Connelly RR; Mostofi FK; Moul JW
    J Urol; 2000 Jan; 163(1):131-6. PubMed ID: 10604330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms?
    Lawton CA; Cantrell JE; Derus SW; Murray KJ; Byhardt RW; Wilson JF
    Radiology; 1994 Jul; 192(1):37-40. PubMed ID: 8208961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
    Abdalla I; Ray P; Vaida F; Vijayakumar S
    Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients.
    Moul JW; Connelly RR; Mooneyhan RM; Zhang W; Sesterhenn IA; Mostofi FK; McLeod DG
    J Urol; 1999 Aug; 162(2):394-7. PubMed ID: 10411045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.